Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rosa María Wong-Chew is active.

Publication


Featured researches published by Rosa María Wong-Chew.


The Journal of Infectious Diseases | 2004

Induction of Cellular and Humoral Immunity after Aerosol or Subcutaneous Administration of Edmonston-Zagreb Measles Vaccine as a Primary Dose to 12-Month-Old Children

Rosa María Wong-Chew; Rocío Islas-Romero; María de Lourdes García-García; Judy Beeler; Susette Audet; José Ignacio Santos-Preciado; Hayley A. Gans; Linda Lew-Yasukawa; Yvonne Maldonado; Ann M. Arvin; José Luis Valdespino-Gómez

Infants were immunized by aerosol (10(3.6) plaque-forming units [pfu]/dose) or subcutaneous (sc) (10(4.27) pfu/dose) administration of Edmonston-Zagreb measles vaccine. Measles-specific T cell proliferative responses with a stimulation index of > or =3 developed in 72% of children given aerosol-administered vaccine, compared with 87% given s.c.-administered vaccine (P =.06). Seroconversion rates were 90% after aerosol-administered vaccine and 100% after s.c.-administered vaccine (P=.01), and measles geometric mean titers were 237 milli-international units (mIU) (95% confidence interval [CI], 146-385 mIU) and 487 mIU (95% CI, 390-609 mIU) in each group, respectively (P=.01). Measles-specific T and B cell responses were weaker after aerosol than after sc vaccination, indicating a need to use a higher aerosol dose to achieve optimal immunogenicity.


Vaccine | 2009

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART

Pablo F. Belaunzarán-Zamudio; Miguel L. García-León; Rosa María Wong-Chew; Angelina Villasís-Keever; Jennifer Cuellar-Rodríguez; Juan L. Mosqueda-Gómez; Teresa Muñoz-Trejo; Kenia Escobedo; Jose I. Santos; Guillermo M. Ruiz-Palacios; Juan Sierra-Madero

OBJECTIVE The objective of the study was to evaluate the immune response to measles vaccine of HIV-infected adults in comparison to HIV non-infected adults. DESIGN We conducted a cross-sectional study to identify adults lacking measles antibodies. 26 HIV-infected patients and 22 controls found to be measles seronegative in the cross-sectional study, received the MMR vaccine. We prospectively followed patients and measured measles antibodies, and cellular proliferative responses against measles antigens. We registered all adverse events at baseline, 3 and 12 months after vaccination. METHODS We determined measles antibodies by ELISA and cellular proliferative response in PBMCs at baseline, and repeated measurements at 3 and 12 months after vaccination. RESULTS The humoral immune response to the vaccine between HIV-infected adults and the HIV-uninfected group was not statistically different at 3 months (81% vs. 86% respectively). One year after vaccination, a higher proportion of HIV-infected adults had lost measles antibodies in contrast to controls. The cellular response was not statistically different between the groups at baseline, 3 and 12 months after immunization despite the waning of antibodies at 12 months. No severe adverse events were observed. Most patients were receiving HAART and had a mean CD4+ cell count of 496 cells/mL. CONCLUSIONS The initial humoral immune response to measles vaccine was not different between HIV-infected adults and HIV-uninfected adults. However, HIV-infected adults have a rapid decline of measles antibodies despite their high CD4+ cell count and sustained cellular proliferative response.


The Journal of Infectious Diseases | 2011

Increasing the Time of Exposure to Aerosol Measles Vaccine Elicits an Immune Response Equivalent to That Seen in 9-Month-Old Mexican Children Given the Same Dose Subcutaneously

Rosa María Wong-Chew; Miguel L. García-León; Bogart Espinosa-Torres Torrija; Brenda Hernández-Pérez; Lino Eduardo Cardiel-Marmolejo; Judy Beeler; Susette Audet; José Ignacio Santos-Preciado

BACKGROUND A 30-second aerosol measles vaccination successfully primes children 12 months of age and older but is poorly immunogenic when given to 9-month-old children. We examined the immune responses when increasing the duration to aerosol exposure in 9-month-olds. METHODS One hundred and thirteen healthy 9-month-old children from Mexico City were enrolled; 58 received aerosol EZ measles vaccine for 2.5 minutes and 55 subcutaneously. Measles-specific neutralizing antibodies and cellular responses were measured before and at 3 and 6 months postimmunization. RESULTS Adaptive immunity was induced in 97% after aerosol and 98% after subcutaneous administration. Seroconversion rates and GMCs were 95% and 373 mIU/mL (95% confidence interval [CI], 441-843) following aerosol vaccination and 91% and 306 mIU/mL (95% CI, 367-597) after subcutaneous administration at 3 months. The percentage of children with a measles-specific stimulation index ≥3 was 45% and 60% in the aerosol versus 55% and 59% in the subcutaneous group at 3 and 6 months, respectively. CD8 memory cell frequencies were higher in the aerosol group at 3 months compared with the subcutaneous group. Adverse reactions were comparable in both groups. CONCLUSIONS Increasing exposure time to aerosol measles vaccine elicits immune responses that are comparable to those seen when an equivalent dose is administered by the subcutaneous route in 9-month-old infants.


PLOS ONE | 2014

Is There Still Room for Novel Viral Pathogens in Pediatric Respiratory Tract Infections

Blanca Taboada; Marco A. Espinoza; Pavel Isa; Fernando E. Aponte; Jesús Monge-Martínez; Rubén Rodríguez-Vázquez; Fidel Díaz-Hernández; Fernando Zárate-Vidal; Rosa María Wong-Chew; Verónica Firo-Reyes; Carlos N. del Río-Almendárez; Jesús Gaitán-Meza; Alberto Villaseñor-Sierra; Gerardo Martinez-Aguilar; Ma. del Carmen Salas-Mier; Daniel E. Noyola; Luis F. Pérez-González; Susana López; José Ignacio Santos-Preciado; Carlos F. Arias

Viruses are the most frequent cause of respiratory disease in children. However, despite the advanced diagnostic methods currently in use, in 20 to 50% of respiratory samples a specific pathogen cannot be detected. In this work, we used a metagenomic approach and deep sequencing to examine respiratory samples from children with lower and upper respiratory tract infections that had been previously found negative for 6 bacteria and 15 respiratory viruses by PCR. Nasal washings from 25 children (out of 250) hospitalized with a diagnosis of pneumonia and nasopharyngeal swabs from 46 outpatient children (out of 526) were studied. DNA reads for at least one virus commonly associated to respiratory infections was found in 20 of 25 hospitalized patients, while reads for pathogenic respiratory bacteria were detected in the remaining 5 children. For outpatients, all the samples were pooled into 25 DNA libraries for sequencing. In this case, in 22 of the 25 sequenced libraries at least one respiratory virus was identified, while in all other, but one, pathogenic bacteria were detected. In both patient groups reads for respiratory syncytial virus, coronavirus-OC43, and rhinovirus were identified. In addition, viruses less frequently associated to respiratory infections were also found. Saffold virus was detected in outpatient but not in hospitalized children. Anellovirus, rotavirus, and astrovirus, as well as several animal and plant viruses were detected in both groups. No novel viruses were identified. Adding up the deep sequencing results to the PCR data, 79.2% of 250 hospitalized and 76.6% of 526 ambulatory patients were positive for viruses, and all other children, but one, had pathogenic respiratory bacteria identified. These results suggest that at least in the type of populations studied and with the sampling methods used the odds of finding novel, clinically relevant viruses, in pediatric respiratory infections are low.


Virology Journal | 2015

Rhinovirus is an important pathogen in upper and lower respiratory tract infections in Mexican children

Fernando E. Aponte; Blanca Taboada; Marco A. Espinoza; Jesús Monge-Martínez; Rubén Rodríguez-Vázquez; Fidel Díaz-Hernández; Fernando Zárate-Vidal; Rosa María Wong-Chew; Verónica Firo-Reyes; Carlos N. del Río-Almendárez; Jesús Gaitán-Meza; Alberto Villaseñor-Sierra; Gerardo Martinez-Aguilar; Maricela García-Borjas; Daniel E. Noyola; Luis F. Pérez-González; Susana López; José Ignacio Santos-Preciado; Carlos F. Arias

BackgroundMost of the studies characterizing the incidence of rhinovirus (RV) have been carried out in hospitalized children and in developed countries. In those studies, RV-C has been associated with more severe respiratory tract infections than RV species A and B. In this study we determined the frequency and diversity of RV strains associated with upper and lower respiratory tract infections (URTI, LRTI) in Mexico, and describe the clinical characteristics of the illness associated with different RV species.MethodsA prospective surveillance of 526 and 250 children with URTI and LRTI was carried out. Respiratory samples were analyzed by RT-PCR for viruses. The 5′ untranslated region of the RV genome was amplified and sequenced.ResultsIn the case of URTI, 17.5% were positive for RV, while this virus was found in 24.8% of LRTI. The RV species was determined in 73 children with URTI: 61.6% were RV-A, 37% RV-C and, 1.4% RV-B; and in 43 children with LRTI: 51.2% were RV-A, 41.8% RV-C, and 7% RV-B. No significant differences in clinical characteristics were found in patients with RV-A or RV-C infections. A high genetic diversity of RV strains was found in both URTI and LRTI.ConclusionsBoth RV-A and RV-C species were frequently found in hospitalized as well as in outpatient children. This study underlines the high prevalence and genetic diversity of RV strains in Mexico and the potential severity of disease associated with RV-A and RV-C infections.


Salud Publica De Mexico | 2010

Frecuencia de virus respiratorios y características clínicas de niños que acuden a un hospital en México

Rosa María Wong-Chew; René Farfán-Quiroz; José Luis Sánchez-Huerta; Margarita Nava-Frías; Jesús Casasola-Flores; José Ignacio Santos-Preciado

OBJETIVO. Describir la frecuencia de virus respiratorios y caracteristicas clinicas en ninos con cuadros respiratorios de un hospital de tercer nivel en Mexico. MATERIAL Y METODOS. Se incluyeron ninos con diagnostico de infeccion respiratoria y un resultado positivo por inmunofluorescencia de enero 2004 a octubre 2006. RESULTADOS. De 986 muestras nasofaringeas, 138 (14%) fueron positivas. La frecuencia fue: 80% virus sincicial respiratorio (VSR), 8% parainfluenza 1, 5% parainfluenza3, 2% adenovirus, 2% influenza A, 1% parainfluenza 2 y 1% influenza B. CONCLUSIONES. La frecuencia de virus respiratorios fue de 14%. El VSR se identifico asociado con mas frecuencia, a neumonia y bronquiolitis en menores de 3 anos.


Journal of Clinical Microbiology | 2014

PhyloFlu, a DNA Microarray for Determining the Phylogenetic Origin of Influenza A Virus Gene Segments and the Genomic Fingerprint of Viral Strains

Luis F. Paulin; María de los Dolores Soto-del Río; Iván Sánchez; Jesús Otero Hernández; Rosa M. Gutiérrez-Rı́os; Irma López-Martínez; Rosa María Wong-Chew; Aurora Parissi-Crivelli; Pavel Isa; Susana López; Carlos F. Arias

ABSTRACT Recent evidence suggests that most influenza A virus gene segments can contribute to the pathogenicity of the virus. In this regard, the hemagglutinin (HA) subtype of the circulating strains has been closely surveyed, but the reassortment of internal gene segments is usually not monitored as a potential source of an increased pathogenicity. In this work, an oligonucleotide DNA microarray (PhyloFlu) designed to determine the phylogenetic origins of the eight segments of the influenza virus genome was constructed and validated. Clades were defined for each segment and also for the 16 HA and 9 neuraminidase (NA) subtypes. Viral genetic material was amplified by reverse transcription-PCR (RT-PCR) with primers specific to the conserved 5′ and 3′ ends of the influenza A virus genes, followed by PCR amplification with random primers and Cy3 labeling. The microarray unambiguously determined the clades for all eight influenza virus genes in 74% (28/38) of the samples. The microarray was validated with reference strains from different animal origins, as well as from human, swine, and avian viruses from field or clinical samples. In most cases, the phylogenetic clade of each segment defined its animal host of origin. The genomic fingerprint deduced by the combined information of the individual clades allowed for the determination of the time and place that strains with the same genomic pattern were previously reported. PhyloFlu is useful for characterizing and surveying the genetic diversity and variation of animal viruses circulating in different environmental niches and for obtaining a more detailed surveillance and follow up of reassortant events that can potentially modify virus pathogenicity.


International Journal of Infectious Diseases | 2017

Respiratory viruses detected in Mexican children younger than 5 years old with community-acquired pneumonia: a national multicenter study☆

Rosa María Wong-Chew; Miguel L. García-León; Daniel E. Noyola; Luis Fernando Perez Gonzalez; Jesús Gaitan Meza; Alberto Vilaseñor-Sierra; Gerardo Martinez-Aguilar; Victor Hugo Rivera-Nuñez; Oscar Alberto Newton-Sánchez; Verónica Firo-Reyes; Carlos N. del Río-Almendárez; Alejandra Pamela Gonzalez-Rodriguez; Enrique R. Ortiz-García; Susana Navarrete-Navarro; Carmen Soria-Rodríguez; Adoniram Carrasco-Castillo; Eneida Sánchez-Medina; Irma López-Martínez; Teresa Hernández-Andrade; Celia Alpuche-Aranda; José Ignacio Santos-Preciado

Abstract Background Acute respiratory infections are the leading cause of mortality in children worldwide, especially in developing countries. Pneumonia accounts for 16% of all deaths of children under 5 years of age and was the cause of death of 935000 children in 2015. Despite its frequency and severity, information regarding its etiology is limited. The aim of this study was to identify respiratory viruses associated with community-acquired pneumonia (CAP) in children younger than 5 years old. Methods One thousand four hundred and four children younger than 5 years of age with a clinical and/or radiological diagnosis of CAP in 11 hospitals in Mexico were included. Nasal washes were collected, placed in viral medium, and frozen at −70°C until processing. The first 832 samples were processed using the multiplex Bio‐Plex/Luminex system and the remaining 572 samples using the Anyplex multiplex RT-PCR. Clinical data regarding diagnosis, clinical signs and symptoms, radiographic pattern, and risk factors were obtained and recorded. Results Of the samples tested, 81.6% were positive for viruses. Respiratory syncytial virus (types A and B) was found in 23.7%, human enterovirus/rhinovirus in 16.6%, metapneumovirus in 5.7%, parainfluenza virus (types 1–4) in 5.5%, influenza virus (types A and B) in 3.6%, adenovirus in 2.2%, coronavirus (NL63, OC43, 229E, and HKU1) in 2.2%, and bocavirus in 0.4%. Co-infection with two or more viruses was present in 22.1%; 18.4% of the samples were negative. Using biomass for cooking, daycare attendance, absence of breastfeeding, and co-infections were found to be statistically significant risk factors for the presence of severe pneumonia. Conclusions Respiratory syncytial virus (types A and B), human enterovirus/rhinovirus, and metapneumovirus were the respiratory viruses identified most frequently in children younger than 5 years old with CAP. Co-infection was present in an important proportion of the children.


Enfermedades Infecciosas Y Microbiologia Clinica | 2018

Comparison of two multiplex PCR techniques for the study of respiratory viruses in Mexican children with pneumonia

Miguel L. García-León; Daniel E. Noyola; Rosa María Wong-Chew

Acute respiratory tract infections (ARI) are the main cause of morbidity and mortality in children worldwide. The WHO estimated that 920,136 deaths occurred in children less than 5 years old due to pneumonia in 2015.1 In Mexico, ARI were the leading cause of disease in 2016.2 The first multiplex PCR assay for respiratory viruses approved by the U.S FDA was the xTAG-RVPTM (Luminex). In Mexico, the InDRE (National Reference Institute for Diagnosis), uses this method for detection of respiratory viruses. However, the cost is high and a special infrastructure is needed. The AnyplexTM II RV16 was introduced in Mexico in 2013 at a more accessible cost. This kit was approved by the European Community (November 2012), the Canadian Department of Health (July 2012) and the Korea FDA (2013) for the diagnosis of respiratory viruses.3,4 The aim of this study was to compare two multiplex PCR techniques for the detection of respiratory viruses in 310 samples of children with pneumonia. From March 2010 to August 2013, 310 samples were included from 1404 children from 1 month to 5 years old with clinical or radiological diagnosis of pneumonia admitted at six different hospitals in Mexico. After written informed consent from the parents or guardians, nasal washes were obtained from children using saline solution which was instilled in each nostril using a catheter, aspirated and diluted 1:1 with viral culture media, aliquoted, and stored at −80 ◦C until processing. One aliquot was sent to the InDRE for viral detection by xTAG-RVP and another aliquot was processed simultaneously by the Anyplex II RV16 at the Faculty of Medicine, UNAM. The gold standard was a construct (the same result with both techniques, and those with discrepancies were sequenced). Virus frequencies, sensitivity, specificity, positive and negative predictive values and kappa coefficient were calculated. A total of 271 samples (87.4%) were positive for a virus with either technique; 246 (79.4%) using RV16 and 243 (78.4%) with xTAG-RVP. Overall, the most frequently detected viruses were


Genome Announcements | 2016

Complete Genome Sequence of Human Coronavirus OC43 Isolated from Mexico

B. T. Taboada; Pavel Isa; Marco A. Espinoza; Fernando E. Aponte; Jesús Monge-Martínez; Rubén Rodríguez-Vázquez; Fidel Díaz-Hernández; Fernando Zárate-Vidal; Rosa María Wong-Chew; Verónica Firo-Reyes; C. N. del Río-Almendárez; Jesús Gaitán-Meza; Alberto Villaseñor-Sierra; Gerardo Martinez-Aguilar; M. García-Borjas; D. E. Noyola; Luis F. Pérez-González; Susana López; José Ignacio Santos-Preciado; Carlos F. Arias

ABSTRACT We report the complete genome sequence of the first Mexican human coronavirus (HCoV) OC43, obtained by new-generation sequencing and a metagenomic approach, isolated from a child hospitalized with pneumonia. The genome is closely related to the other OC43 genome sequences available, ranging from 99.8% to 98.2% nucleotide sequence identity.

Collaboration


Dive into the Rosa María Wong-Chew's collaboration.

Top Co-Authors

Avatar

José Ignacio Santos-Preciado

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar

Miguel L. García-León

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar

Carlos F. Arias

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar

Susana López

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar

Daniel E. Noyola

Universidad Autónoma de San Luis Potosí

View shared research outputs
Top Co-Authors

Avatar

Fernando E. Aponte

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar

Gerardo Martinez-Aguilar

Mexican Social Security Institute

View shared research outputs
Top Co-Authors

Avatar

Marco A. Espinoza

National Autonomous University of Mexico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Judy Beeler

Food and Drug Administration

View shared research outputs
Researchain Logo
Decentralizing Knowledge